rebel em

the move-out trial: molnupiravir – oral antivirals for management of covid-19? by marco propersi posted january 27, 2022 no comments background: on december 23, 2021, the fda granted molnupiravir emergency use authorization for the treatment of patients with covid-19. molnupiravir is a nucleoside analog that inhibits sars-cov-2 replication and triggers … read more latest posts ... read more